Skip to main content

Posts

Showing posts with the label Inlyta

FDA Approves Inlyta to treat patients who suffer from a type of advanced kidney cancer

U.S. Food   and Drug Administration   today   approved   Inlyta (axitinib) for the treatment of   patients with   advanced   kidney cancer   ( renal cell carcinoma ) and those who   did not respond to   another drug   for this type of   cancer. Renal cell carcinoma   is a type of   kidney cancer   that starts   in the lining of   very   small tubes   in the kidneys.   Inlyta   works by blocking certain proteins   called   kinases   that play   a role in   tumor growth and cancer progression .   Inlyta   is a pill   that patients   take   twice a day.